2015
DOI: 10.1378/chest.14-3161
|View full text |Cite
|
Sign up to set email alerts
|

The Use of Inhaled Prostaglandins in Patients With ARDS

Abstract: In ARDS, inhaled prostaglandins improve oxygenation and decrease pulmonary artery pressures and may be associated with harm. Data are limited both in terms of methodologic quality and demonstration of clinical benefit. The use of inhaled prostaglandins in ARDS needs further study.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
129
0
2

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 115 publications
(136 citation statements)
references
References 62 publications
5
129
0
2
Order By: Relevance
“…PG is one of them but its role in ARDS is not clear. [12][13][14][15] In the present study also, inhibition of PG synthesis by indomethacin pretreatment killed the animals within 15 min of OA administration as reported earlier indicating a beneficial role of PG in ARDS. Further, improvement in the RF, HR, MAP, and lung injury when PGE1 analog (misoprostol) was given as pretreatment along with indomethacin, indicates that PGs play a protective role in ARDS.…”
Section: Discussionsupporting
confidence: 87%
“…PG is one of them but its role in ARDS is not clear. [12][13][14][15] In the present study also, inhibition of PG synthesis by indomethacin pretreatment killed the animals within 15 min of OA administration as reported earlier indicating a beneficial role of PG in ARDS. Further, improvement in the RF, HR, MAP, and lung injury when PGE1 analog (misoprostol) was given as pretreatment along with indomethacin, indicates that PGs play a protective role in ARDS.…”
Section: Discussionsupporting
confidence: 87%
“…Another meta-analysis of 25 studies showed that inhaled prostacyclin improved oxygenation and decreased pulmonary artery pressures but may be associated with harm by producing hypotension. 7 ECMO is a technique that dissociates mechanical ventilation and gas exchange, thereby reducing ventilator-associated lung injury. Multiple studies have evaluated the effect of ECMO on mortality in subjects with severe acute respiratory failure.…”
Section: See the Original Study On Page 127mentioning
confidence: 99%
“…Compared with iNO, inhaled prostanoids require no special application and monitoring equipment, and are therefore easier and less expensive to administer. This could be the reason for the increase in use over time in the treatment of ARDS [33], although there is no clinical data showing a mortality benefit and large scale randomized clinical trials (RCTs) are lacking [34]. In a meta-analysis in 2015, Fuller et al [34] demonstrate that inhaled prostaglandins improve oxygenation and decrease pulmonary artery pressures.…”
Section: Introductionmentioning
confidence: 99%
“…This could be the reason for the increase in use over time in the treatment of ARDS [33], although there is no clinical data showing a mortality benefit and large scale randomized clinical trials (RCTs) are lacking [34]. In a meta-analysis in 2015, Fuller et al [34] demonstrate that inhaled prostaglandins improve oxygenation and decrease pulmonary artery pressures. On the other hand, they also lower systemic pressure, with hypotension occurring in 17.4% of patients in observational studies [34].…”
Section: Introductionmentioning
confidence: 99%